Indication | Used in the treatment of acute or chronic schizophrenic reactions in hospitalized patients. |
Pharmacodynamics | Carphenazine is a phenothiazine antipsychotic agent with a piperazine side-chain. |
Mechanism of action | A yellow, powdered, phenothiazine antipsychotic agent used in the treatment of acute or chronic schizophrenia. The term "phenothiazines" is used to describe the largest of the five main classes of neuroleptic antipsychotic drugs. These drugs have antipsychotic and, often, antiemetic properties, although they may also cause severe side effects such as akathisia, tardive dyskinesia and extrapyramidal symptoms. Carphenazine blocks postsynaptic mesolimbic dopaminergic D1 and D2 receptors in the brain; depresses the release of hypothalamic and hypophyseal hormones and is believed to depress the reticular activating system thus affecting basal metabolism, body temperature, wakefulness, vasomotor tone, and emesis. |
Absorption | Not Available |
Volume of distribution | Not Available |
Protein binding | Not Available |
Metabolism | Not Available |
Route of elimination | Not Available |
Half life | Not Available |
Clearance | Not Available |
Toxicity | Not Available |
Saturday, October 13, 2012
Pharmacology Of Carphenazine
Labels:
Pharmacology of Drugs,
UNCLASSIFIED
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment